In today’s cut-throat competitive environment it is imperative to have as much knowledge and information about the competitors as possible, this not only helps in understanding the potential challenges and opportunities but also in risk mitigation.
MedDx covers various aspects of competitive intelligence:

Conference coverage: Scientific &/or medical conferences are one of the pivotal sources for keeping the biopharma industry abreast with the most recent activities ongoing in the space and provide an opportunity to interact with KOLs and industry experts, and know their perspective on a particular asset/product/MoA/technology/treatment modality. These congresses, therefore, have become extremely important from primary and secondary research CI standpoint.

Constant Monitoring: Real time tracking of news and key updates/events and their implications on the disease/treatment landscape or on company’s product.

Product / Competitor / Trial profiling: In-depth assessment of assets/companies/trials and profiling helps client understand what competitors are aiming at and therefore take the necessary measures to remain ahead of the competition in the market.